NO974309D0 - HCG væskeformuleringer - Google Patents

HCG væskeformuleringer

Info

Publication number
NO974309D0
NO974309D0 NO974309A NO974309A NO974309D0 NO 974309 D0 NO974309 D0 NO 974309D0 NO 974309 A NO974309 A NO 974309A NO 974309 A NO974309 A NO 974309A NO 974309 D0 NO974309 D0 NO 974309D0
Authority
NO
Norway
Prior art keywords
hcg
soln
liquid formulations
polyalcohol
mannitol
Prior art date
Application number
NO974309A
Other languages
English (en)
Other versions
NO974309L (no
NO318997B1 (no
Inventor
Fabrizio Samaritani
Patrizia Natale
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of NO974309D0 publication Critical patent/NO974309D0/no
Publication of NO974309L publication Critical patent/NO974309L/no
Publication of NO318997B1 publication Critical patent/NO318997B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Semiconductor Memories (AREA)
  • Polyurethanes Or Polyureas (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO19974309A 1995-03-21 1997-09-18 Stabil, flytende farmasoytisk sammensetning, samt fremgangsmate til fremstilling og presentasjonsform derav. NO318997B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP1995/001055 WO1996029095A1 (en) 1995-03-21 1995-03-21 Hcg liquid formulations

Publications (3)

Publication Number Publication Date
NO974309D0 true NO974309D0 (no) 1997-09-18
NO974309L NO974309L (no) 1997-10-14
NO318997B1 NO318997B1 (no) 2005-05-30

Family

ID=8165977

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19974309A NO318997B1 (no) 1995-03-21 1997-09-18 Stabil, flytende farmasoytisk sammensetning, samt fremgangsmate til fremstilling og presentasjonsform derav.

Country Status (16)

Country Link
US (1) US6706681B1 (no)
EP (1) EP0814841B1 (no)
JP (1) JP4165718B2 (no)
KR (1) KR100377967B1 (no)
AT (1) ATE209930T1 (no)
AU (1) AU707796B2 (no)
BR (1) BR9510567A (no)
DE (1) DE69524456T2 (no)
DK (1) DK0814841T3 (no)
ES (1) ES2166841T3 (no)
FI (1) FI117160B (no)
HK (1) HK1006365A1 (no)
NO (1) NO318997B1 (no)
PT (1) PT814841E (no)
UA (1) UA61053C2 (no)
WO (1) WO1996029095A1 (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6319504B1 (en) 1996-06-24 2001-11-20 University Of Maryland Biotechnology Institute Treatment and prevention of HIV infection by administration of derivatives of human chorionic gonadotropin
IL122732A0 (en) * 1997-01-15 1998-08-16 Akzo Nobel Nv Liquid gonadotropin-containing formulation its preparation and a device containing same
KR100548107B1 (ko) * 1997-01-30 2006-02-02 바이오팜 게젤샤프트 쭈어 바이오테히놀로지셴 엔트비클룽 폰 파르마카 엠베하 뼈 유도 인자 인간 ｍｐ52 동결 건조 조성물
CN100482679C (zh) 2000-02-22 2009-04-29 雪兰诺实验室有限公司 人绒毛膜促性腺激素的纯化方法
WO2002011753A1 (fr) * 2000-08-04 2002-02-14 Chugai Seiyaku Kabushiki Kaisha Preparations proteiniques a injecter
FR2869979B1 (fr) * 2004-05-06 2006-08-04 Packinox Sa Echangeur thermique a plaques
KR101105871B1 (ko) * 2005-09-27 2012-01-16 주식회사 엘지생명과학 인 난포자극호르몬의 안정한 용액 제형
KR20080106636A (ko) * 2007-06-04 2008-12-09 동아제약주식회사 사람 융모성 성선자극호르몬 함유 즉시 사용형 주사 용액
MY153976A (en) * 2007-11-01 2015-04-30 Merck Serono Sa Lh liquid formulations
TWI532495B (zh) * 2009-10-05 2016-05-11 菲瑞茵國際中心股份有限公司 藥學製劑
WO2011108010A2 (en) * 2010-03-05 2011-09-09 Intas Biopharmaceuticals Limited A thermostable liquid formulation of gonadotropins
EP2417982A1 (en) 2010-07-30 2012-02-15 Ferring B.V. Stabilization of gonadotropins
US20120265129A1 (en) 2011-04-15 2012-10-18 Neuralight Hd, Llc Methods for Chronic Pain Management and Treatment using HCG
US8680086B2 (en) 2011-04-15 2014-03-25 Neuralight Hd, Llc Methods for chronic pain management and treatment using HCG
MX2015004940A (es) 2012-10-18 2015-12-09 Neuralight Hd Llc Tratamiento de depresion y ptsd.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL88233A (en) * 1987-11-03 1993-08-18 Genentech Inc Gamma interferon formulation
IE64738B1 (en) * 1990-03-20 1995-09-06 Akzo Nv Stabilized gonadotropin containing preparations
US5385230A (en) * 1991-01-11 1995-01-31 Minnesota Mining And Manufacturing Company Adjustable tray assembly for use in desk drawers
JP2966592B2 (ja) * 1991-07-20 1999-10-25 萩原 義秀 安定化されたヒトモノクローナル抗体製剤
IT1250075B (it) * 1991-12-18 1995-03-30 Serono Cesare Ist Ricerca Composizioni farmaceutiche contenenti gonadotropine.

Also Published As

Publication number Publication date
US6706681B1 (en) 2004-03-16
KR19980702859A (ko) 1998-08-05
ATE209930T1 (de) 2001-12-15
HK1006365A1 (en) 1999-02-26
PT814841E (pt) 2002-03-28
WO1996029095A1 (en) 1996-09-26
DK0814841T3 (da) 2002-03-04
DE69524456D1 (de) 2002-01-17
NO974309L (no) 1997-10-14
NO318997B1 (no) 2005-05-30
EP0814841A2 (en) 1998-01-07
JP4165718B2 (ja) 2008-10-15
DE69524456T2 (de) 2002-08-01
AU707796B2 (en) 1999-07-22
JPH11502205A (ja) 1999-02-23
FI973745A (fi) 1997-11-11
EP0814841B1 (en) 2001-12-05
FI973745A0 (fi) 1997-09-22
FI117160B (fi) 2006-07-14
UA61053C2 (en) 2003-11-17
ES2166841T3 (es) 2002-05-01
KR100377967B1 (ko) 2003-06-12
BR9510567A (pt) 1998-06-23
AU2110695A (en) 1996-10-08

Similar Documents

Publication Publication Date Title
ATE209930T1 (de) Flüssige hcg-formulierungen
ES2190087T3 (es) Formulacion estabilizada de un anticuerpo.
ITMI930578A0 (it) Metodo e dispositivo per salvare un'immagine di sitema su una memoria permanate, in modo indipendente dal sistema operativo
DE69434304D1 (de) Pharmazeutische Zusammensetzungen zur intranasalen Verabreichung von Dihydroergotamin
ATE189608T1 (de) Gonadotropin, das pharmazeutische zusammensetzungen mit sucrose stabilisator enthält
FR2690147B1 (fr) Plate-forme, notamment pour cabine d'ascenseur et monte-charge, en materiau composite.
EP0764446A3 (en) An adjuvanted vaccine which is substantially free of non-host albumin
ATE172770T1 (de) Stabknoten
AU7315596A (en) Pharmaceutical composition for topical application
Hunter Modern and ancient coral associations of the Cayman Islands
Pleydell Aspects of diagenesis and ichnology in the Olioocene-Miocene Bluff Formation of Grand Cayman Island, British West Indies
AU2001258638A1 (en) Methods for identifying modulators of the interaction between lap (latency associated peptide) and intergrin alpha.v.beta.3 and medical use thereof
IT8919481A0 (it) Sistema di articolazione per mobili e suo procedimento di montaggio.
MX9707121A (es) Formulaciones liquidas de gch.
IT8820618A0 (it) Forma farmaceutica e supporto per la somministrazione di estratti ellergenici.
Scott Construction guidelines for concrete slabs. Part 1. Design.
龚雁 The Sorrow and the Strength
孟昭辉 inter—noise 87
Singaravélou Wink, A.-Al Hind. The Making of the Indo-Islamic World. Vol. I. Early medieval India and the expansion of Islam 7-1 1 th Centuries, 1990
ITTO920090U1 (it) Sistema di fondazione, in particolare per la realizzazione di micropali e/o di tiranti di ancoraggio.
ITBO930096A1 (it) Sistema per la realizzazione di rilevati, muri di controripa, scarpate in terra rinforzata e simili.
ITRE910030A1 (it) Lancia erogatrice particolarmente per idropulitrici ad alta e bassa pressione.
ITRM920218U1 (it) Sistema di accoppiamento e montaggio di pannelli per la formazione di pareti mobili.
IT236326Y1 (it) Sistema di fondazione per la realizzazione di micropali e/o di tirantidi ancoraggio.
CA2133995A1 (en) Method and composition for the treatment of disorders involving immunological dysfunction

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: ONSAGERS AS, POSTBOKS 6963 ST OLAVS PLASS, 0130 OS

CREP Change of representative

Representative=s name: ZACCO NORWAY AS, POSTBOKS 2003 VIKA, 0125 OSLO, NO

MK1K Patent expired